Distinct clinical profiles and mutation landscapes of gliomas originating from the neocortex, mesocortex, and cerebellum

Ye Cheng; Lei Zhang; Xiaolong Wu; Hiroaki Wakimoto; Haoming Geng; Yukui Wei; Geng Xu; Xinru Xiao; Jie Bai; Yaming Wang; Zeliang Hu; Leiming Wang; Qingtang Lin

doi:10.1016/j.gendis.2023.02.044

您当前的位置：

首页 >

文章列表页 >

Distinct clinical profiles and mutation landscapes of gliomas originating from the neocortex, mesocortex, and cerebellum

Short communication | 更新时间：2024-02-04

- Distinct clinical profiles and mutation landscapes of gliomas originating from the neocortex, mesocortex, and cerebellum
- Genes & Diseases Vol. 1, Issue 1, Pages: 53-56(2024)
- 作者机构：
  
  1. Department of Neurosurgery, Xuanwu Hospital, Capital Medical University,Beijing,China,100053
  2. Brain Tumor Research Center, Massachusetts General Hospital, Department of Neurosurgery, Harvard Medical School,MA,Boston,USA,02134
  3. Department of Pathology, Xuanwu Hospital, Capital Medical University,Beijing,China,100053
- 作者简介：
- 基金信息：
- DOI：10.1016/j.gendis.2023.02.044
  CLC：
- Published：2024，
  
  Published Online：1 January 2024，
扫描看全文
Ye Cheng, Lei Zhang, Xiaolong Wu, et al. Distinct clinical profiles and mutation landscapes of gliomas originating from the neocortex, mesocortex, and cerebellum. [J]. Genes & Diseases 1(1):53-56(2024)
DOI：

Ye Cheng, Lei Zhang, Xiaolong Wu, et al. Distinct clinical profiles and mutation landscapes of gliomas originating from the neocortex, mesocortex, and cerebellum. [J]. Genes & Diseases 1(1):53-56(2024) DOI： 10.1016/j.gendis.2023.02.044.

摘要

Abstract

关键词

Keywords

references

1 E. Lopci, M. Riva, L. Olivari, et al.Prognostic value of molecular and imaging biomarkers in patients with supratentorial glioma Eur J Nucl Med Mol Imag, 44 (7) (2017), pp. 1155-1164

2 R. Stupp, M.E. Hegi, W.P. Mason, et al.Effects of radiotherapy with concomitant and adjuvant temozolomide versus radiotherapy alone on survival in glioblastoma in a randomised phase III study: 5-year analysis of the EORTC-NCIC trial Lancet Oncol, 10 (5) (2009), pp. 459-466

3 Y.W. Park, S.S. Ahn, C.J. Park, et al.Diffusion and perfusion MRI may predict EGFR amplification and the TERT promoter mutation status of IDH-wildtype lower-grade gliomas Eur Radiol, 30 (12) (2020), pp. 6475-6484

4 K. Aldape, G. Zadeh, S. Mansouri, et al.Glioblastoma: pathology, molecular mechanisms and markers Acta Neuropathol, 129 (6) (2015), pp. 829-848

5 Q. Wang, B. Hu, X. Hu, et al.Tumor evolution of glioma-intrinsic gene expression subtypes associates with immunological changes in the microenvironment Cancer Cell, 32 (1) (2017), pp. 42-56.e6

查看原文

Views

下载量

CSCD

Alert me when the article has been cited

提交

Tools